Medical device regulatory insight · 2026-03-25

How to bridge NMPA-compliant Clinical Evaluation evidence with international clinical regulatory compliance

Against the backdrop of increasingly stringent global medical device regulation, how can Chinese clinical data truly gain international acceptance?

In an era of increasingly stringent global medical device regulation, how can Chinese clinical data truly go global?

Clinsota's senior clinical experts willon April 3, 2026, from 14:00 to 16:00, deliver a two-hour live online public-interest course,focusing on clinical evaluation and clinical trials under NMPA compliance,with a systematic analysis of their translation pathways and review logic for overseas regulatory submissions such as EU CE marking and U.S. FDA registration, helping companies establish the critical pathway from Chinese clinical evidence to global market access and achieve efficient, compliant international expansion.

Organizer: Feitian Education Professional Training Platform